Gout is a form of inflammatory arthritis that develops when an excess of uric acid in the blood leads to deposits of uric acid crystals in one or more joints, causing inflammation.
0.8% of Australians had gout in 2014–15, based on self-reported survey data. That is approximately 192,000 people
4x more men than women have gout—8 in 10 (81%) of people with gout are men
Gout can be controlled with early and ongoing treatment, including:
Flares and complications can be managed by reducing risk factors for hyperuricaemia (dehydration, obesity and alcohol intake), taking urate-lowering medications to keep uric acid levels low, and managing comorbid conditions, such as high blood pressure, chronic kidney disease, diabetes and heart disease.
The use of non-steroidal anti-inflammatory drugs (NSAIDs), low-dose colchicine and oral/intra-muscular/intra-articular glucocorticoids has also been found to be effective in managing acute gout. It has been recommended that people with gout should continue urate-lowering therapy for the rest of their lives .
Data from the AIHW National Hospital Morbidity Database (NHMD) show that, in 2015–16:
Source: AIHW National Hospital Morbidity Database (Gout data table).
The age-standardised hospitalisation rate for Australians with gout increased between 2005–06 to 2015–16: from 20 hospitalisations per 100,000 population to 27 per 100,000 population. There was a slightly larger increase for females (43%, from 7 to 10 per 100,000 population) compared with males (35%, from 34 to 46 per 100,000 population).
We'd love to know any feedback that you have about the AIHW website, its contents or reports.